SUPN Short Volume
Supernus Pharmaceuticals, Inc. (SUPN) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry, with a market capitalization near $2.72B, listed on NASDAQ, employing roughly 674 people, carrying a beta of 0.54 to the broader market. Supernus Pharmaceuticals, Inc. Led by Jack A. Khattar, public since 2012-05-01.
Short volume measures the number of shares sold short on a given day as reported by FINRA. Tracking short volume relative to total volume helps identify unusual bearish sentiment or short-squeeze potential.
- Latest Date
- 2026-06-30
- Short Volume
- 147.8K
- Total Volume
- 237.6K
- Short %
- 62.22%
- 30-Day Avg Short %
- 56.36%
Showing 30 days of FINRA short volume data for Supernus Pharmaceuticals, Inc..
Learn how short volume is reported and how to read the data →
Frequently asked SUPN short volume questions
- What is the daily SUPN short volume?
- As of Jun 30, 2026, Supernus Pharmaceuticals, Inc. (SUPN) short volume is 147.8K shares against 237.6K total reported volume, or 62.22% short-side. Short volume measures shares sold short during the day; it is flow, not inventory.
- How is SUPN short volume reported?
- FINRA publishes the Daily Short Sale Volume File for trades reported to FINRA TRFs and the FINRA/Nasdaq ADF on a T+1 basis. The headline figure is the count of shares that printed at the short-sale or short-exempt tick across all reporting venues for the symbol; each exchange separately publishes its own daily short-sale data file.
- What does SUPN short volume tell options traders?
- Daily short-sale flow is one input that helps disambiguate dealer-hedging activity from directional bear flow when the chain shows fresh customer call inventory. It is not a clean MM-only proxy: the headline number mixes directional shorting, options-MM delta-hedging, ETF-creation arbitrage, and convertible-arb hedging. Cross-check against gamma-exposure and OI changes for a cleaner read.